RN-026

N/A

Report date: 2025/06/16 10:28:46
NME

Base Information

Drug NameRN-026
Drug Alias NameRN-026
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionApolipoprotein(a) inhibitors
TargetsApolipoprotein(a)
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A